Learning Objectives:

  1. Understand how the changing definition of preeclampsia affects diagnosis and management
  2. Understand how angiogenic biomarkers help to improve prediction of preeclampsia and its adverse outcomes
  3. Understand how future management, with the help of digital tools, might further improve clinical decision making
Session date: 
02/24/2023 - 8:00am to 9:00am CST
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Stefan Verlohren, MD, PhD